The Net Margin of Shield Therapeutics PLC (STX.L) is -84.47%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -84.47% |
| 2023-12-31 | -254.44% |
| 2022-12-31 | -906.57% |
| 2021-12-31 | -1295.46% |
| 2020-12-31 | -25.32% |
| 2019-12-31 | -1223.92% |
| 2018-12-31 | -15.08% |
| 2017-12-31 | -3075.04% |
| 2016-12-31 | -4939.47% |